select trial semaglutide cardiovascular outcomes non-diabetic 2023 AHA Late Breaking Science: Day 1 Highlights 🫀SELECT Trial: and in Obesity without Diabetes ✓: ⬇️ 20% Risk of a composite of cardiovascular death ❤️, nonfatal myocardial infarction, or SELECT Trial

Semaglutide dosing for weight loss typically reaches 2.4 mg weekly, but individual tolerance and response vary significantly

Discover the side effects of compounded semaglutide, a medication used to treat diabetes and weight loss

Mitigating Side Effects Several strategies have proven effective for managing adverse events: Starting with lower doses (e.g., 0.5 mg) rather than higher doses Implementing gradual dose escalation with adequate time between increases Maintaining patients at current doses longer when side effects emerge Monitoring and providing supportive care for gastrointestinal symptoms[8] These approaches can significantly improve tolerability and adherence to the medication regimen

Our group recently published a peerreviewed case report in JCEM Case Reports describing an atypical retrobulbar optic neuropathy occurring shortly after semaglutide dose escalation

Omada Health targets employer GLP-1 companion care as revenue jumps 53% to $260M

Convenient, prescription-based telehealth treatment from Laylapersonalized for your health goals.